Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Fatty Acyls
Glycerolipids
Glycerophospholipids
Saccharolipids
Sphingolipids
Displaying entries 2001 - 2025 of 2342 in total
Sub Class ▲ LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP05
  • B-IV antigen(d18:1/24:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261848 3050.49321 C134H235N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP06
  • B-IV antigen(d18:1/26:0)
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
 44261849 3078.52451 C136H239N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP07
  • B-IV antigen(d18:1/24:1(15Z))
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44261850 3048.47756 C134H233N5O71
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505EP08
  • B-IV antigen(d18:1/26:1(17Z))
  • Fucalpha1-2(Galalpha1-3)Galbeta1-4GlcNAcbeta1-6(Galalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261851 3076.50886 C136H237N5O71
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA00
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA01
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261948 1064.697118 C54H100N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA02
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/18:0)
 44261949 1092.728418 C56H104N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA03
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261950 1120.759718 C58H108N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA04
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/22:0)
 44261951 1148.791018 C60H112N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA05
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261952 1176.822318 C62H116N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA06
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:0)
 44261953 1204.853618 C64H120N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA07
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44261954 1174.806668 C62H114N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA08
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261955 1202.837968 C64H118N2O18
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AB00
  • CPS
  • GalNAcb1-4(Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer
GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AC00
  • CHS
  • GalNAcb1-4(GlcNAca1-2Fuca1-3)GlcNAcb1-3Manb1-4Glcb-Cer
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA00
  • Manalpha1-3Manbeta1-4Glcbeta-Cer
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA01
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/16:0)
 44261940 1023.670569 C52H97NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA02
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/18:0)
 44261941 1051.701869 C54H101NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA03
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/20:0)
 44261942 1079.733169 C56H105NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA04
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/22:0)
 44261943 1107.764469 C58H109NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA05
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:0)
 44261944 1135.795769 C60H113NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA06
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0)
 44261945 1163.827069 C62H117NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA07
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
 44261946 1133.780119 C60H111NO18
Manalpha1-3Manbeta1-4Glc- (Mollu series) LMSP0507AA08
  • Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
 44261947 1161.811419 C62H115NO18
Other Neutral glycosphingolipids LMSP05000001
  • N-(34S-methyl-5Z,9Z,12Z,15Z,18Z,21Z-hexatriacontahexaenoyl)-1-sulfo-beta-D-fucosyl-(16R-methyl-sphing-4-enine)
  • Syriacin
 52931241 1059.777221 C62H109NO10S
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback

Click here to visit the beta site.

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.0.0

Last updated: August 19, 2024